Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruyu Liu

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|June 1, 2026
HOPX is required for the generation of umbilical cord blood-derived memory-like NK cells induced by three cytokinesZhiqing Liu, Yangyang Lei, Jiaxin Chen, et al.
Cancer Biology & Medicine|May 20, 2026
HBx-mediated GPT2 suppression promotes liver cancer development by downregulating ADH1AHongjuan You, Xing Wang, Ruyu Liu, et al.
Frontiers in Immunology|October 7, 2022
Dynamic changes of cytokine profiles and virological markers during 48 weeks of entecavir treatment for HBeAg-positive chronic hepatitis BMinghui Li, Yuanjiao Gao, Liu Yang, et al.
Frontiers in Immunology|May 23, 2022
Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B PatientsMinghui Li, Luxue Zhang, Si Xie, et al.
Hepatology (Baltimore, Md.)|May 25, 2011
MicroRNAs-372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/BHongyan Guo, Haiying Liu, Keith Mitchelson, et al.
Frontiers in Cellular and Infection Microbiology|June 8, 2026
HBsAg loss in chronic hepatitis B patients with an HBsAg decline plateau can be enhanced by intermittent PEG-IFN treatmentWeihua Cao, Si Xie, Hongxiao Hao, et al.
Frontiers in Medicine|December 2, 2024
Insulin resistance has closer correlation with the occurrence of metabolic dysfunction associated steatotic liver disease diagnosed by liver biopsyWeihua Cao, Tingting Jiang, Wen Deng, et al.
Frontiers in Immunology|December 9, 2022
Study on liver histopathology of chronic HBV infected patients with different normal ALT valuesZhan Zeng, Hongxiao Hao, Xiaoyue Bi, et al.
Biosafety and Health|March 13, 2025
Impact of ursodeoxycholic acid therapy in autoimmune liver disease patients with COVID-19 and its clinical prognosisMinghui Li, Weihua Cao, Tingting Jiang, et al.
Frontiers in Immunology|November 10, 2022
Cytokine profiles and CD8+ T cells in the occurrence of acute and chronic hepatitis BSi Xie, Liu Yang, Xiaoyue Bi, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|June 1, 2026
HOPX is required for the generation of umbilical cord blood-derived memory-like NK cells induced by three cytokinesZhiqing Liu, Yangyang Lei, Jiaxin Chen, et al.
Cancer Biology & Medicine|May 20, 2026
HBx-mediated GPT2 suppression promotes liver cancer development by downregulating ADH1AHongjuan You, Xing Wang, Ruyu Liu, et al.
Frontiers in Immunology|October 7, 2022
Dynamic changes of cytokine profiles and virological markers during 48 weeks of entecavir treatment for HBeAg-positive chronic hepatitis BMinghui Li, Yuanjiao Gao, Liu Yang, et al.
Frontiers in Immunology|May 23, 2022
Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B PatientsMinghui Li, Luxue Zhang, Si Xie, et al.
Hepatology (Baltimore, Md.)|May 25, 2011
MicroRNAs-372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/BHongyan Guo, Haiying Liu, Keith Mitchelson, et al.
Frontiers in Cellular and Infection Microbiology|June 8, 2026
HBsAg loss in chronic hepatitis B patients with an HBsAg decline plateau can be enhanced by intermittent PEG-IFN treatmentWeihua Cao, Si Xie, Hongxiao Hao, et al.
Frontiers in Medicine|December 2, 2024
Insulin resistance has closer correlation with the occurrence of metabolic dysfunction associated steatotic liver disease diagnosed by liver biopsyWeihua Cao, Tingting Jiang, Wen Deng, et al.
Frontiers in Immunology|December 9, 2022
Study on liver histopathology of chronic HBV infected patients with different normal ALT valuesZhan Zeng, Hongxiao Hao, Xiaoyue Bi, et al.
Biosafety and Health|March 13, 2025
Impact of ursodeoxycholic acid therapy in autoimmune liver disease patients with COVID-19 and its clinical prognosisMinghui Li, Weihua Cao, Tingting Jiang, et al.
Frontiers in Immunology|November 10, 2022
Cytokine profiles and CD8+ T cells in the occurrence of acute and chronic hepatitis BSi Xie, Liu Yang, Xiaoyue Bi, et al.
Pageof 7